Hanson Wade

What They Do
From the earliest days of Hanson Wade’s creation, they have sought to provide insights on the most cutting-edge and emerging facets of drug development. What began with a meet-up of academic scientists and biotech CEOs researching circulating tumor cells (CTCs) over 12 years ago, has become a conference portfolio of 200+ niche events, networks, and an industry-defining database service that supports over 25,000 biopharma customers each year.

Their Passion for Science Defines Us
Their passion for deeply researched science defines us, as does their desire to discover emerging fields of biopharma R&D that they can bring clarity to. As scientists by training, their product team talk to those at the forefront of the industry to ensure their products match the complexity and specificity of the drugs that are being developed. They discover the most critical challenges being faced and work with industry to define the solutions that are needed.

Across all therapeutic indications and drug modalities, they are resolute in their belief that for drug developers to get more targeted drugs to the right patients faster, they must provide information, products and services that are as precise and personalized as the drugs they are informing.